Translation of these findings into prevention or treatment of human breast cancer will require attention to several research gaps, including identification of common and relevant VDR targets in distinct breast cancer subtypes, clarification of the mechanisms and importance of accumulation and turnover of vitamin D metabolites in tumors, and discovery of regulatory mechanisms that enhance vitamin D signaling in the TME. The gene discussed is VDR; the disease is breast carcinoma.